The administration sequences of immune checkpoint inhibitors and chemotherapy cause discrete efficacy when treating non-small cell lung cancer: a retrospective study

The administration sequences of immune checkpoint inhibitors and chemotherapy cause discrete efficacy when treating non-small cell lung cancer: a retrospective study

BackgroundImmune checkpoint inhibitors (ICIs) combined with chemotherapy have become a standard first-line treatment for advanced non-small cell lung cancer (NSCLC). However, the optimal sequence of administrating the two treatments remains controversial.MethodsThis study included advanced NSCLC pat...

Full description

Saved in:
Bibliographic Details
Main Authors: Bicheng Zhang, Yuxiao Song, Qian Min, Weiting Cheng, Jun Wang, Yang Fu, Jiaxin Yin
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Immunology
Subjects:
immune checkpoint inhibitors
chemotherapy
administration sequence
efficacy
non-small cell lung cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1579420/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items